FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, namely to gel for treatment of infected wounds, and can be used for treatment and healing of superficial wounds of various aetiologies. Antibacterial agent in the form of a gel contains an aminoglycoside antibiotic - gentamycin, a thickener - hydroxypropyl methylcellulose, dimethylsulfoxide, derivative of 2(5H)-furanone-5(S)-[(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yloxy]-3-chloro-4-[(4-chlorophenyl)sulfonyl]-2(5H)-furanone as an antimicrobial agent of gentamycin and water, wherein the substances are taken in the following ratio: hydroxypropyl methylcellulose 2 g, dimethyl sulphoxide 10 g, gentamycin 50 mg, 2(5H)-furanone derivative 4 mg, water - 88 g.
EFFECT: invention provides high antibacterial activity of the gel and accelerated wound healing.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
| CHIRAL ZINC COMPLEXES WITH ETHYLENEDIAMINE TERPENE DERIVATIVES | 2022 |
|
RU2785281C1 |
| NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
| 2,6-DIISOBORNYL PHENOL DERIVATIVES | 2011 |
|
RU2575294C2 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| N-HETEROCYCLIC BORNYL AMINE DERIVATIVES AS ORTHOPOXVIRUS INHIBITORS | 2018 |
|
RU2687254C1 |
| CHIRAL COPPER(II) COMPLEXES WITH TERPENIC DERIVATIVES OF ETHYLENEDIAMINE AND APPLICATION THEREOF AS AGENT EXHIBITING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY | 2020 |
|
RU2756043C1 |
| 2,6-DIISOBORNYLPHENOLS | 2011 |
|
RU2502719C2 |
| ALKYL-PYRIDAZINE DERIVATIVES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1(11β-HSD 1) | 2007 |
|
RU2417989C2 |
| N-BORNIL- AND N-PHENCHYLCARBOXAMIDES USED AS ORTHOPOXVIRUS REPLICATION INHIBITORS | 2022 |
|
RU2800448C1 |
